Tradestie Institutional Equity Comparison Engine

CTMX vs CRMD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CRMD Overall Edge

CRMD Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CorMedix Inc. (CRMD) driven by superior Valuation, Growth & Margin, Options & Structure while CTMX counters with relative strength in Momentum & Technical. Fundamentally, CTMX trades at 14.2x Forward P/E with -676.4% operating margin (-71.7% YoY revenue) versus CRMD at 49.0x Forward P/E and 41.0% operating margin (-47.7% YoY). In options structure, CTMX sits in BREAKDOWN (60th %ile IV; Dealer Gamma Walls on Pro) against CRMD sits in BREAKDOWN (25th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CRMD
CTMX 14.2x vs CRMD 49.0x Fwd P/E
Growth & Margin Winner CRMD
Op Margin -676.4% vs 41.0% ยท YoY -71.7% vs -47.7%
Momentum & Technical Winner CTMX
1Y -49.4% vs -56.2% ยท 52W Pos 1% vs 3%
Options & Structure Winner CRMD
BREAKDOWN (60th %ile IV) vs BREAKDOWN (25th %ile IV)
CTMX NASDAQ
CytomX Therapeutics, Inc.
Pharmaceutical Preparations
$1.96
-4.17% 1D
Market Cap $436.0M
1M Return -14.25%
1Y Return -49.35%
Forward P/E 14.2x
Unified AI Score
53.1 / 100 HOLD
Tech 66.0 Fund 64.0 Flow 69.0 Mom 49.0
CRMD NASDAQ
CorMedix Inc.
Pharmaceutical Preparations
$4.92
+5.47% 1D
Market Cap $384.7M
1M Return -32.3%
1Y Return -56.16%
Forward P/E 49.0x
Unified AI Score
53.2 / 100 HOLD
Tech 60.0 Fund 60.0 Flow 69.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CTMX -49.35% CRMD -56.16% Spread: +6.81 pp (CTMX Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CTMX Revenue CRMD Revenue CTMX Op. Margin CRMD Op. Margin Margin Edge
FY2018 $60M $0M -130.9% -6250.4% CTMX
FY2019 $30M $0M -525.9% -7416.3% CTMX
FY2020 $70M $0M -117.7% -11378.4% CTMX
FY2021 $40M $0M -311.0% -15417.5% CTMX
FY2022 $50M $0M -190.6% -46819.9% CTMX
FY2023 $100M N/A -6.4% N/A CTMX
FY2024 $140M $40M 18.1% -51.4% CTMX
FY2025 $80M $310M -29.3% 48.2% CRMD

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CTMX (3) vs CRMD (6)
Institutional Metric CTMX CRMD Criterion Row Winner
Market Capitalization Scale $436.0M $384.7M Larger Scale CTMX
Trailing P/E Ratio Valuation 14.2x 2.4x Lower Multiple CRMD
Forward P/E Ratio Valuation 14.2x 49.0x Lower Multiple CTMX
Revenue Growth (YoY) Growth -71.7% -47.7% Higher Growth CRMD
Operating Margin (TTM) Profitability -676.4% 41.0% Higher Margin CRMD
Net Profit Margin Profitability 0.0% 15.5% Higher Margin CRMD
Return on Equity (ROE) Capital Efficiency -43.5% 15.3% Higher ROE CRMD
52-Week Range Position Momentum 1% ($2โ€“$8) 3% ($5โ€“$13) Stronger Trend CRMD
Beta / 30D Volatility Risk Regime 1.48ฮฒ ยท 78% Vol 1.20ฮฒ ยท 107% Vol Lower Realized Risk CTMX
Unified Institutional Score Composite Signal 53.1 / 100 (HOLD) 53.2 / 100 (HOLD) Higher Composite Tie

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CTMX vs CRMD Buy Guide
CTMX BREAKDOWN
170d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 60th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live CTMX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CRMD BREAKDOWN
109d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 25th %ile
IV Regime Compressed (<25th %ile)
Live CRMD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CTMX nor CRMD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.